In an effort to expand its ophthalmic clinical research services, iuvo BioScience has acquired Promedica International, according to a press release.
With the acquisition, iuvo appointed Promedica International (PMI) president and owner Shannon Stoddard as its president of clinical research. Stoddard will also serve on the board of directors at iuvo.
“Shannon’s employee-centric and sponsor-dedicated approach is a perfect strategic and cultural fit with the iuvo team,” Ben Burton, iuvo president and CEO, said in the release. “Under Shannon’s leadership, we will